| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Michael T Brooks last filed a Form 4 in June 2019, as Director at MLAB. Michael T Brooks's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 32,730 shares of MLAB. The MLAB filings lean toward selling, a net 4,700 shares.
Michael T Brooks has 16 Form 4 filings on record from April 2015 to June 2019, all as Director at Mesa Laboratories (MLAB), 2015–2019.
The 29 reported transactions were 13 option exercises, 6 other transactions, 4 option or other derivative awards and 2 gifts, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $773K.
The largest open-market sale was 2,700 shares of MLAB at an average $195.39 on September 10, 2018, about $528K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.